These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29891609)

  • 41. Developmental pharmacokinetics and pharmacodynamics of nizatidine.
    Abdel-Rahman SM; Johnson FK; Connor JD; Staiano A; Dupont C; Tolia V; Winter H; Gauthier-Dubois G; Kearns GL
    J Pediatr Gastroenterol Nutr; 2004 Apr; 38(4):442-51. PubMed ID: 15085026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
    Mori M; Fukushima K; Miharu M; Goto H; Yoshida M; Shoji S
    J Infect Chemother; 2013 Feb; 19(1):174-9. PubMed ID: 22714745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea.
    Mancuso AM; Gandhi MA; Slish J
    J Pharm Pract; 2018 Apr; 31(2):195-201. PubMed ID: 28490220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota.
    Rashid MU; Rosenborg S; Panagiotidis G; Holm J; Söderberg Löfdal K; Weintraub A; Nord CE
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4244-51. PubMed ID: 27139483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study.
    Raber S; Courtney R; Maeda-Chubachi T; Simons BD; Freedman SF; Wirostko B;
    Ophthalmology; 2011 Oct; 118(10):2022-7. PubMed ID: 21788077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.
    Smith PB; Cotten CM; Hudak ML; Sullivan JE; Poindexter BB; Cohen-Wolkowiez M; Boakye-Agyeman F; Lewandowski A; Anand R; Benjamin DK; Laughon MM;
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.
    Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH
    J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and safety of voriconazole intravenous-to-oral switch regimens in immunocompromised Japanese pediatric patients.
    Mori M; Kobayashi R; Kato K; Maeda N; Fukushima K; Goto H; Inoue M; Muto C; Okayama A; Watanabe K; Liu P
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1004-13. PubMed ID: 25451051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
    Barbhaiya RH; Marathe PH; Greene DS; Mayol RF; Shukla UA; Gammans RR; Pittman KA; Robinson D
    J Clin Pharmacol; 1995 Oct; 35(10):974-84. PubMed ID: 8568015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.
    Donald BJ; Surani S; Deol HS; Mbadugha UJ; Udeani G
    Drug Des Devel Ther; 2017; 11():3559-3566. PubMed ID: 29263651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.
    Furfaro LL; Spiller OB; Keelan JA; Payne MS
    Int J Antimicrob Agents; 2015 Sep; 46(3):319-24. PubMed ID: 26141231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.
    Purkins L; Wood N; Greenhalgh K; Allen MJ; Oliver SD
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):10-6. PubMed ID: 14616408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
    Purkins L; Wood N; Greenhalgh K; Eve MD; Oliver SD; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):2-9. PubMed ID: 14616407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area.
    Vanstraelen K; Colita A; Bica AM; Mols R; Augustijns P; Peersman N; Vermeersch P; Annaert P; Spriet I
    Pediatr Infect Dis J; 2016 Feb; 35(2):183-8. PubMed ID: 26544987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease.
    Hey JA; Yu JY; Versavel M; Abushakra S; Kocis P; Power A; Kaplan PL; Amedio J; Tolar M
    Clin Pharmacokinet; 2018 Mar; 57(3):315-333. PubMed ID: 29063518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics of intravenous bolus etomidate in children over 6 months of age.
    Lin L; Zhang JW; Huang Y; Bai J; Cai MH; Zhang MZ
    Paediatr Anaesth; 2012 Apr; 22(4):318-26. PubMed ID: 21917057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers.
    Jones A; Wang-Smith L; Pham T; Laliberte K
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):227-32. PubMed ID: 24603117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis.
    Mohamed MF; Camp HS; Jiang P; Padley RJ; Asatryan A; Othman AA
    Clin Pharmacokinet; 2016 Dec; 55(12):1547-1558. PubMed ID: 27272171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.